- Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
Guohao Liu et al, 2022, Pharmaceutics CrossRef - STAT3 phosphorylation inhibitor Bt354 exhibits anti‐neoplastic activity in glioblastoma multiforme cells
Yi‐Chun Chiang et al, 2024, Environmental Toxicology CrossRef - STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo et al, 2022, Pharmacological Research CrossRef - Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
Elisha Hayden et al, 2021, Cancers CrossRef - Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
Valentina Di Ruscio et al, 2022, Diagnostics CrossRef - Engineered extracellular vesicles (EVs): Promising diagnostic/therapeutic tools for pediatric high-grade glioma
Yuan Lyu et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
Zirong Chen et al, 2021, Cancers CrossRef - Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives
Marziyeh Salami et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef - Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness
Stefano Ratti et al, 2022, Cellular and Molecular Life Sciences CrossRef - STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
Liang Zhang et al, 2022, Neuro-Oncology CrossRef - Radiotherapy and radio‐sensitization in H3K27M‐mutated diffuse midline gliomas
Chao Liu et al, 2023, CNS Neuroscience & Therapeutics CrossRef